Corporate Presentation 1 Leader in AAV Gene Therapy 7 | 18 | 2022 Forward-looking statements This presentation includes "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements express a belief, expectation or intention and are generally accompanied by words that convey projected future events or outcomes such as "believe," "may," "will," "estimate," "continue," "anticipate, ...

REGENXBIO Inc. (NASDAQ:RGNX) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President and CEO Steve Pakola - Chief Medical Officer Vit Vasista - CFO Conference Call Participants Andreas Argyrides - Wedbush Securities Operator Good day and thank you for standing by. Welcome to the Q1 2022 REGENXBIO Inc. Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers’ presentation, there wil ...

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Patrick Christmas – Chief Legal Officer Ken Mills – President and Chief Executive Officer Steve Pakola – Chief Medical Officer Vit Vasista – Chief Financial Officer Conference Call Participants Alec Stranahan – Bank of America Dane Leone – Raymond James Mani Foroohar – SVB Leerink Andreas Argyrides – Wedbush Operator Thank you for joining Q4 2021 REGENXBIO Inc. Earnings Conference Call. At this time, ...

REGENXBIO Inc. (NASDAQ:RGNX) Q3 2021 Earnings Conference Call November 2, 2021 4:30 PM ET Company Participants Patrick Christmas – Chief Legal Officer Ken Mills – President and Chief Executive Officer Steve Pakola – Chief Medical Officer Vit Vasista – Chief Financial Officer Conference Call Participants Gena Wang – Barclays Mani Foroohar – SVB Leerink Vikram Purohit – Morgan Stanley Esther Rajavelu – UBS Dane Leone – Raymond James Luca Issi – RBC Capital Operator Good afternoon and welcome to the REGENXBIO ...

Call Start: 16:30 January 1, 0000 5:30 PM ET REGENXBIO Inc. (NASDAQ:RGNX) Q2 2021 Earnings Conference Call August 9, 2021 16:30 ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President & Chief Executive Officer Steve Pakola - Chief Medical Officer Vit Vasista - Chief Financial Officer Conference Call Participants Alec Stranahan - Bank of America Gena Wang - Barclays Dane Leone - Raymond James Matthew Harrison - Morgan Stanley Luca Issi - RBC Capital Dane Leone - Raymond James Es ...

REGENXBIO Inc. (NASDAQ:RGNX) Q1 2021 Results Conference Call May 5, 2021 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President and CEO Dr. Steve Pakola - Chief Medical Officer Conference Call Participants Alec Stranahan - Bank of America Gena Wang - Barclays Gbola Amusa - Chardan Esther Rajavelu - UBS Kostas Biliouris - Morgan Stanley Lisa Walter - RBC Operator Good afternoon, and welcome to the REGENXBIO First Quarter 2021 Earnings Conference Call. At this time, all ...

REGENXBIO Inc. (NASDAQ:RGNX) Q4 2020 Earnings Conference Call March 1, 2021 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President and CEO Steve Pakola - Chief Medical Officer Olivier Danos - Chief Scientific Officer Vit Vasista - CFO Conference Call Participants Esther Rajavelu - UBS Lisa Walter - RBC Capital Operator Good afternoon, and welcome to the REGENXBIO Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participants are in a listen- ...

REGENXBIO, Inc. (NASDAQ:RGNX) Q3 2020 Results Earnings Conference Call November 4, 2020 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President and CEO Steve Pakola - Chief Medical Officer Vit Vasista - CFO Conference Call Participants Gena Wang - Barclays Gbola Amusa - Chardan Lisa Walter - RBC Capital Markets Gbola Amusa - Chardan Operator Good afternoon and welcome to the REGENXBIO Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a l ...

REGENXBIO, Inc. (NASDAQ:RGNX) Q2 2020 Earnings Conference Call August 6, 2020 4:30 PM ET Company Participants Patrick Christmas – Chief Legal Officer Ken Mills – President and Chief Executive Officer Steve Pakola – Chief Medical Officer Vit Vasista – Chief Financial Officer Conference Call Participants Gena Wang – Barclays Alec Stranahan – Bank of America Mani Foroohar – SVB Sam Lee – Chardan Connor McGuinness Meehan – Morgan Stanley Luca Issi – RBC Capital Operator Good afternoon and welcome to the REGENXB ...

Corporate Presentation Leader in AAV Gene Therapy June 16, 2020 Forward-looking statements This presentation includes "forward-looking statements," within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements express a belief, expectation or intention and are generally accompanied by words that convey projected future events or outcomes such as "believe," "may," "will," "estimate," "continue," "anticipate," ...